(1)
A Clinical Case of Successful Treatment of HER2-Low Disseminated Breast Cancer With Trastuzumab Deruxtecan. Вопр. онкол. 2023, 69 (4), 757-760. https://doi.org/10.37469/0507-3758-2023-69-4-757-760.